miR-10b and miR-223-3p in serum microvesicles signal progression from prediabetes to type 2 diabetes.

We have identified a miRNA signature in serum microvesicles that can be used as a new screening biomarker to identify subjects with prediabetes at high risk of developing diabetes, hence allowing the implementation of earlier, and probably more effective, therapeutic interventions.